Cited by 394Gut microbiota and healthDialysis and Renal Disease ManagementGastrointestinal motility and disorders

The DOI matches its Crossref record; 163 of the 165 references it cites were found in a registry or an index.

Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target

Open access

Ramezani, Ali, Massy, Ziad A., Meijers, Björn, Evenepoel, Pieter, Vanholder, Raymond, Raj, Dominic S.·2016·American Journal of Kidney Diseases

DOI 10.1053/j.ajkd.2015.09.027PMC PMC5408507

Open this paper in CoChat — free account Open PDF

Abstract

Also known as the "second human genome," the gut microbiome plays important roles in both the maintenance of health and the pathogenesis of disease. The symbiotic relationship between host and microbiome is disturbed due to the proliferation of dysbiotic bacteria in patients with chronic kidney disease (CKD). Fermentation of protein and amino acids by gut bacteria generates excess amounts of potentially toxic compounds such as ammonia, amines, thiols, phenols, and indoles, but the generation of short-chain fatty acids is reduced. Impaired intestinal barrier function in patients with CKD permits translocation of gut-derived uremic toxins into the systemic circulation, contributing to the progression of CKD, cardiovascular disease, insulin resistance, and protein-energy wasting. The field of microbiome research is still nascent, but is evolving rapidly. Establishing symbiosis to treat uremic syndrome is a novel concept, but if proved effective, it will have a significant impact on the management of patients with CKD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.ajkd.2015.09.027

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597

Show all 165 references

Research works printed but not linked: 1

Ringoir, 1986, Proceedings of the Ghent Symposium on Uremic Toxins, Adv Exp Med Biol, 223, 59

Sorted by citations

The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
Wang, X., Yang, S., Li, S., Zhao, L., Hao, Y., Qin, J., Zhang, L., Zhang, C., Bian, W., Zuo, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319766 · Cited by 553
Trimethylamine N-oxide: the good, the bad and the unknown.
Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504
Self-citation
Microbial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440
Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease
Chen, Y., Chen, D., Chen, L., Liu, J., Vaziri, N. D., Guo, Y. P., & Zhao, Y. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-018-1756-4 · Cited by 430
Gut Microbiota and Complications of Type-2 Diabetes
Iatcu, O. C., Steen, A., & Covașă, M. (2021) · Nutrients · doi:10.3390/nu14010166 · Cited by 448
The Impact of CKD on Uremic Toxins and Gut Microbiota
Rysz, J., Franczyk, B., Ławiński, J., Olszewski, R., Ciałkowska-Rysz, A. D., & Gluba-Brzózka, A. (2021) · Toxins · doi:10.3390/toxins13040252 · Cited by 324
Distant Organ Dysfunction in Acute Kidney Injury: A Review
Lee, S. A., Cozzi, M., Bush, E. L., & Rabb, H. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.03.028 · Cited by 303
Protein nutrition and malnutrition in CKD and ESRD
Zha, Y., & Qian, Q. (2017) · Nutrients · doi:10.3390/nu9030208 · Cited by 292
Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver Injury
Saeedi, B. J., Liu, K. H., Owens, J. A., Hunter-Chang, S., Camacho, M. C., Eboka, R. U., Chandrasekharan, B., Baker, N. F., Darby, T. M., Robinson, B. S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.006 · Cited by 295
Obesity and chronic kidney disease
Jiang, Z., Wang, Y., Zhao, X., Cui, H., Han, M., Ren, X., Gang, X., & Wang, G. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2022 · Cited by 267
Gut microbiome in chronic kidney disease: challenges and opportunities
Nallu, A., Sharma, S., Ramezani, A., Jagadeesan, M., & Raj, D. (2016) · Translational research · doi:10.1016/j.trsl.2016.04.007 · Cited by 263
Self-citation
Membrane transporters in drug development and as determinants of precision medicine
Galetin, A., Brouwer, K. L. R., Tweedie, D., Yoshida, K. J., Sjöstedt, N., Aleksunes, L. M., Chu, X., Evers, R., Hafey, M. J., Lai, Y., et al. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00877-1 · Cited by 250
Inflammation and premature aging in advanced chronic kidney disease
Kooman, J. P., Dekker, M. J. E., Usvyat, L. A., Kotanko, P., SANDE, F. M. V. D., Schalkwijk, C. G., Shiels, P. G., & Stenvinkel, P. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00256.2017 · Cited by 248
Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis
Sabatino, A., Regolisti, G., Karupaiah, T., Sahathevan, S., Singh, B. K. S., Khor, B., Salhab, N., Karavetian, M., Cupisti, A., & Fiaccadori, E. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.06.007 · Cited by 219
Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
Hung, S., Kuo, K., Wu, C., & Tarng, D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005022 · Cited by 216
Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM)
Tănase, D. M., Gosav, E. M., Neculae, E., Costea, C. F., Ciocoiu, M., Hurjui, L. L., Tărniceriu, C. C., Maranducă, M. A., Lăcătușu, C.-M., Floria, M., et al. (2020) · Nutrients · doi:10.3390/nu12123719 · Cited by 210
Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron?
Buret, A. G., Motta, J., Allain, T., Ferraz, J. G., & Wallace, J. L. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0495-4 · Cited by 213
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease
Sabatino, A., Regolisti, G., Cosola, C., Gesualdo, L., & Fiaccadori, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0841-z · Cited by 202
Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD
Al-Obaide, M. A. I., Singh, R., Datta, P., Rewers-Felkins, K., Salguero, M. V., Al‐Obaidi, I., Kottapalli, K. R., & Vasylyeva, T. L. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6090086 · Cited by 208
The impact of gut microbiota on kidney function and pathogenesis
Mahmoodpoor, F., Saadat, Y. R., Barzegari, A., Ardalan, M., & Vahed, S. Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.066 · Cited by 172
Immune Dysfunction in Uremia 2020
Cohen, G. (2020) · Toxins · doi:10.3390/toxins12070439 · Cited by 178
Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy
Fernandes, R., Viana, S., Nunes, S., & Reis, F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.032 · Cited by 171
Gut microbiota–derived short-chain fatty acids and kidney diseases
Li, L., Ma, L., & Fu, P. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s150825 · Cited by 164
Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis
Li, X., Shan, Q., Wu, X., Miao, H., & Zhao, Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05532-5 · Cited by 167
Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease
Mafra, D., Borges, N. A., Alvarenga, L., Esgalhado, M., Cardozo, L., Lindholm, B., & Stenvinkel, P. (2019) · Nutrients · doi:10.3390/nu11030496 · Cited by 155
Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis
Mikusic, N. L. R., Kouyoumdzian, N. M., & Choi, M. R. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02352-x · Cited by 155
Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression
Castillo-Rodríguez, E., Fernández-Prado, R., Esteras, R., Pérez-Gómez, M. V., Gracia-Iguacel, C., Fernández‐Fernández, B., Kanbay, M., Tejedor, A., Lázaro, A., Ruiz‐Ortega, M., et al. (2018) · Toxins · doi:10.3390/toxins10070300 · Cited by 154
Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors
Pluznick, J. L. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.033 · Cited by 153
Constipation in CKD
Sumida, K., Yamagata, K., & Kovesdy, C. P. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.11.002 · Cited by 153
The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage
Plaza‐Díaz, J., Solis‐Urra, P., Rodríguez‐Rodríguez, F., Arancibia, J. E. O., Navarro-Oliveros, M., Abadía‐Molina, F., & Álvarez‐Mercado, A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218351 · Cited by 150
Microbiota intestinal en la enfermedad renal crónica
Cigarrán, S., Parra, E. G., & Cases, A. (2016) · Nefrología · doi:10.1016/j.nefro.2016.05.008 · Cited by 153
The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice
Zhou, W., Wu, W., Si, Z.-L., Liu, H., Wang, H., Jiang, H., Liu, Y., Alolga, R. N., Chen, C., Liu, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33824-6 · Cited by 140
Immunology of the ageing kidney
Sato, Y., & Yanagita, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0185-9 · Cited by 126
Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials
Zheng, H., Guo, J., Wang, Q., Wang, L., Wang, Y., Zhang, F., Huang, W., Zhang, W., Liu, W. J., & Wang, Y. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1740645 · Cited by 122
Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome
Chu, W., Han, Q., Xu, J., Wang, J., Sun, Y., Li, W., Chen, Z.-J., & Du, Y. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.01.027 · Cited by 121
Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease
Gao, H., & Liu, S. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.027 · Cited by 117
Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation
Magliocca, G., Mone, P., Iorio, B. R. D., Heidland, A., & Marzocco, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105354 · Cited by 130
Blood Microbiome Profile in CKD
Shah, N. B., Allegretti, A. S., Nigwekar, S. U., Kalim, S., Zhao, S. J., Lelouvier, B., Servant, F., Serena, G., Thadhani, R., Raj, D. S., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12161018 · Cited by 115
Self-citation
The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature
Stanford, J., Charlton, K. E., Stefoska‐Needham, A., Ibrahim, R., & Lambert, K. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01805-w · Cited by 123
Lymphocytes and innate immune cells in acute kidney injury and repair
Lee, K., Jang, H. R., & Rabb, H. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00875-5 · Cited by 131
Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease
Fernández-Prado, R., Esteras, R., Pérez-Gómez, M. V., Gracia-Iguacel, C., González‐Parra, E., Sanz, A. B., Ortíz, A., & Sánchez-Niño, M. D. (2017) · Nutrients · doi:10.3390/nu9050489 · Cited by 109
Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis
Amornphimoltham, P., Yuen, P. S. T., Star, R. A., & Leelahavanichkul, A. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05581-y · Cited by 109
Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability
Tsunoda, S. M., Gonzales, C., Jarmusch, A. K., Momper, J. D., & JOSEPH, D. R. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01032-y · Cited by 120
Characteristics of Colon-Derived Uremic Solutes
Mair, R. D., Sirich, T. L., Plummer, N. S., & Meyer, T. W. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03150318 · Cited by 105
Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial
Mafi, A., Namazi, G., Soleimani, A., Bahmani, F., Aghadavod, E., & Asemi, Z. (2018) · Food & Function · doi:10.1039/c8fo00888d · Cited by 102
Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease
Cosola, C., Rocchetti, M. T., Cupisti, A., & Gesualdo, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.003 · Cited by 99
The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease
Chi, M., Ma, K., Wang, J., Ding, Z., Li, Y., Zhu, S., Liang, X., Zhang, Q., Song, L., & Liu, C. (2021) · Journal of Immunology Research · doi:10.1155/2021/5516035 · Cited by 103
Does Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients?
Black, A. P., Anjos, J. S., Cardozo, L., Carmo, F. L., Dolenga, C., Nakao, L., Ferreira, D. D. C., Rosado, A., Carraro-Eduardo, J. C., & Mafra, D. (2018) · Journal of renal nutrition · doi:10.1053/j.jrn.2017.11.007 · Cited by 86
Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins
de Brito, J. S., Borges, N. A., Esgalhado, M., Magliano, D. C., Soulage, C. O., & Mafra, D. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000476074 · Cited by 95
Obesity-related kidney disease: Beyond hypertension and insulin-resistance
Arabi, T. Z., Shafqat, A., Sabbah, B. N., Ashraf, N., Shah, H., Abdulkader, H. S., Razak, A., Sabbah, A. N., & Arabi, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1095211 · Cited by 102
Uremic Toxin Clearance and Cardiovascular Toxicities
Mair, R. D., Sirich, T. L., & Meyer, T. W. (2018) · Toxins · doi:10.3390/toxins10060226 · Cited by 94
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
Huang, Y., Xin, W., Xiong, J., Yao, M., Zhang, B., & Zhao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837500 · Cited by 93
Gut microbiome in chronic kidney disease
Wing, M. R., Patel, S. S., Ramezani, A., & Raj, D. S. (2015) · Experimental Physiology · doi:10.1113/ep085283 · Cited by 93
Self-citation
Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights
Snelson, M., Kellow, N. J., & Coughlan, M. T. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy068 · Cited by 89
The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics
Mazhar, S. F., Afzal, M., Almatroudi, A., Munir, S., Ashfaq, U. A., Rasool, M., Raza, H., Munir, H. M. W., Rajoka, M. S. R., & Khurshid, M. (2020) · Journal of Food Quality · doi:10.1155/2020/9676452 · Cited by 90
Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study
Borges, N. A., Stenvinkel, P., Bergman, P., Qureshi, A. R., Lindholm, B., Moraes, C., Stockler-Pinto, M. B., & Mafra, D. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9411-1 · Cited by 83
Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease
Kikuchi, M., Ueno, M., Itoh, Y., Suda, W., & Hattori, M. (2017) · Nephron · doi:10.1159/000450619 · Cited by 82
Organ crosstalk: the potent roles of inflammation and fibrotic changes in the course of organ interactions
Armutçu, F. (2019) · Inflammation Research · doi:10.1007/s00011-019-01271-7 · Cited by 80
Microphysiological Systems to Recapitulate the Gut–Kidney Axis
Giordano, L., Mihaila, S. M., Amirabadi, H. E., & Masereeuw, R. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.12.001 · Cited by 83
Inflammation: A Key Contributor to the Genesis and Progression of Chronic Kidney Disease
Qian, Q. (2017) · Contributions to nephrology · doi:10.1159/000479257 · Cited by 79
The gut–kidney–heart axis in chronic kidney disease
Sumida, K., & Kovesdy, C. P. (2019) · Physiology International · doi:10.1556/2060.106.2019.19 · Cited by 80
Modulation of gut‐microbiota through probiotics and dietary interventions to improve host health
Dasriya, V. L., Samtiya, M., Ranveer, S. A., Dhillon, H. S., Devi, N., Sharma, V., Nikam, P., Puniya, M., Chaudhary, P., Chaudhary, V., et al. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13370 · Cited by 85
Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques
Sato, E., Saigusa, D., Mishima, E., Uchida, T., Miura, D., Morikawa, T., Kisu, K., Sekimoto, A., Saito, R., Oe, Y., et al. (2017) · Toxins · doi:10.3390/toxins10010019 · Cited by 79
Causal Effects of Specific Gut Microbiota on Chronic Kidney Diseases and Renal Function—A Two-Sample Mendelian Randomization Study
Li, N., Wang, Y., Wei, P., Yu, M., Yu, M., Zhou, G., Yuan, G., Sun, J., Dai, H., Zhou, E., et al. (2023) · Nutrients · doi:10.3390/nu15020360 · Cited by 77
Homeostasis in the Gut Microbiota in Chronic Kidney Disease
Bhargava, S., Merckelbach, E., Noels, H., Vohra, A., & Jankowski, J. (2022) · Toxins · doi:10.3390/toxins14100648 · Cited by 77
Chronic kidney disease and gut microbiota
Khiabani, S. A., Asgharzadeh, M., & Kafil, H. S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18991 · Cited by 80
Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake
Cupisti, A., D’Alessandro, C., Gesualdo, L., Cosola, C., Gallieni, M. A., Egidi, M. F., & Fusaro, M. (2017) · Nutrients · doi:10.3390/nu9050444 · Cited by 74
Functional characteristic of microbial communities in large-scale biotreatment systems of food waste
Wang, P., Qiao, Z., Li, X., Su, Y., & Xie, B. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141086 · Cited by 72
Rhubarb Enema Improved Colon Mucosal Barrier Injury in 5/6 Nephrectomy Rats May Associate With Gut Microbiota Modification
Ji, C., Deng, Y., Yang, A., Lu, Z., Chen, Y., Liu, X., Han, L., & Zou, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01092 · Cited by 73
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
Cosola, C., Rocchetti, M. T., di Bari, I., Acquaviva, P. M., Maranzano, V., Corciulo, S., Ciaula, A. D., Palo, D. M. D., la Forgia, F. M., Fontana, S., et al. (2021) · Toxins · doi:10.3390/toxins13050334 · Cited by 72
Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes—A Systematic Review
Voroneanu, L. E., Burlacu, A., Brinza, C., Covic, A. S., Bălan, G. G., Nistor, I., Popa, C. A., Hogas, S. M., & Covic, A. C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051948 · Cited by 77
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)
Simeoni, M., Citraro, M. L., Cerantonio, A., Deodato, F., Provenzano, M., Cianfrone, P., Capria, M., Corrado, S., Libri, E., Comi, A., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1785-z · Cited by 70
Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn’s disease
Kong, L., Lloyd-Price, J., Vatanen, T., Seksik, P., Beaugerie, L., Simon, T., Vlamakis, H., Sokol, H., & Xavier, R. J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.045 · Cited by 69
Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review
Chung, S.-Y., Barnes, J. L., & Astroth, K. S. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz028 · Cited by 72
Gut microbiota in chronic kidney disease
Cigarrán, S., Parra, E. G., & Cases, A. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.01.017 · Cited by 71
Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet
Ikee, R., Sasaki, N., Yasuda, T., & Fukazawa, S. (2020) · Microorganisms · doi:10.3390/microorganisms8121862 · Cited by 65
Gut Microbiome in Chronic Kidney Disease
Armani, R. G., Ramezani, A., Yasir, A., Sharama, S., Canziani, M. E., & Raj, D. S. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0727-0 · Cited by 68
Self-citation
From obesity through gut microbiota to cardiovascular diseases: a dangerous journey
Marzullo, P., Renzo, L. D., Pugliese, G., Siena, M. D., Barrea, L., Muscogiuri, G., Colao, A., & Savastano, S. (2020) · International Journal of Obesity Supplements · doi:10.1038/s41367-020-0017-1 · Cited by 64
Protein-bound uremic toxins impaired mitochondrial dynamics and functions
Sun, C., Cheng, M., Pan, H., Lee, J.-H., & Lee, C. (2017) · Oncotarget · doi:10.18632/oncotarget.20773 · Cited by 62
The Role of Probiotics in Purine Metabolism, Hyperuricemia and Gout: Mechanisms and Interventions
James, A., Ke, H., Yao, T., & Wang, Y. (2021) · Food Reviews International · doi:10.1080/87559129.2021.1904412 · Cited by 65
Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial
McFarlane, C. M., Krishnasamy, R., Stanton, T., Savill, E., Snelson, M., Mihala, G., Kelly, J. T., Morrison, M., Johnson, D. W., & Campbell, K. L. (2021) · Nutrients · doi:10.3390/nu13124481 · Cited by 61
Environmental Chemical Diethylhexyl Phthalate Alters Intestinal Microbiota Community Structure and Metabolite Profile in Mice
Lei, M., Menon, R., Manteiga, S., Alden, N., Hunt, C. L., Alaniz, R. C., Lee, K., & Jayaraman, A. (2019) · mSystems · doi:10.1128/msystems.00724-19 · Cited by 65
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Saxami, G., Kerezoudi, E. N., Eliopoulos, C., Arapoglou, D., & Kyriacou, A. (2023) · Life · doi:10.3390/life13102023 · Cited by 65
The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation
Yu, W., Sun, S., Yan, Y., Zhou, H., Liu, Z., & Fu, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1519925 · Cited by 70
Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD
Kortman, G. A. M., Reijnders, D., & Swinkels, D. W. (2017) · Hemodialysis International · doi:10.1111/hdi.12553 · Cited by 60
Effect of Dietary Inulin Supplementation on the Gut Microbiota Composition and Derived Metabolites of Individuals Undergoing Hemodialysis: A Pilot Study
Biruete, A., Cross, T.-W., Allen, J. M., Kistler, B. M., de Loor, H., Evenepoel, P., Fahey, G. C., Jr., Bauer, L. L., Swanson, K. S., & Wilund, K. R. (2021) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2020.10.003 · Cited by 59
Self-citation
Preventive Effects of Lactobacillus Mixture against Chronic Kidney Disease Progression through Enhancement of Beneficial Bacteria and Downregulation of Gut-Derived Uremic Toxins
Huang, H., Li, K., Lee, Y., & Chen, M. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01547 · Cited by 58
Inflammation in Children with CKD Linked to Gut Dysbiosis and Metabolite Imbalance
Holle, J. B., Bartolomaeus, H., Löber, U., Behrens, F., Bartolomaeus, T. U. P., Anandakumar, H., Wimmer, M. I., Vu, D. L., Kuhring, M., Brüning, U., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022030378 · Cited by 60
Gut microbiome-related metabolic changes in plasma of antibiotic-treated rats
Behr, C., Kamp, H., Fabian, E. J., Krennrich, G., Mellert, W., Peter, R. E., Strauss, V., Walk, T. B., Rietjens, I. M. C. M., & van Ravenzwaay, B. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1949-2 · Cited by 59
Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients
He, S., Xiong, Q., Tian, C., Li, L., Zhao, J., Lin, X., Guo, X., He, Y., Liang, W., Zuo, X., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02669-y · Cited by 56
Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature
Feng, Z., Wang, T., Dong, S., Jiang, H., Zhang, J., Raza, H. K., & Lei, G. (2021) · Journal of International Medical Research · doi:10.1177/03000605211053276 · Cited by 56
Vascular Calcification: An Important Understanding in Nephrology
Vahed, S. Z., Mostafavi, S., Khatibi, S. M. H., Shoja, M. M., & Ardalan, M. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s242685 · Cited by 55
Microbiome modulation as a novel therapeutic approach in chronic kidney disease
Sumida, K., Lau, W. L., Kovesdy, C. P., Kalantar‐Zadeh, K., & Kalantar‐Zadeh, K. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000661 · Cited by 57
The Regulation of Host Intestinal Microbiota by Polyphenols in the Development and Prevention of Chronic Kidney Disease
Bao, N. T. Y., Chen, F., & Dai, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02981 · Cited by 53
Gut microbiota and renal transplant outcome
Ardalan, M., & Vahed, S. Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.114 · Cited by 52
Gut Microbiome and Organ Fibrosis
Costa, C. F. F. A., Sampaio‐Maia, B., Araújo, R., Nascimento, D. S., Ferreira‐Gomes, J., Pestana, M., Azevedo, M. J., & Alencastre, I. S. (2022) · Nutrients · doi:10.3390/nu14020352 · Cited by 53
An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease
Altamura, S., Pietropaoli, D., Lombardi, F., Pinto, R. D., & Ferri, C. (2023) · Biomedicines · doi:10.3390/biomedicines11113033 · Cited by 64
The Effect of Polyphenol-Rich Interventions on Cardiovascular Risk Factors in Haemodialysis: A Systematic Review and Meta-Analysis
Marx, W., Kelly, J. T., Marshall, S., Nakos, S., Campbell, K. L., & Itsiopoulos, C. (2017) · Nutrients · doi:10.3390/nu9121345 · Cited by 51
Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD
Szeto, C., McIntyre, C. W., & Li, P. K. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018010068 · Cited by 51

Authors: Ramezani, A., Massy, Z. A., Meijers, B., Evenepoel, P., Vanholder, R., & Raj, D. S.
Affiliations: George Washington University (US)
Inserm (FR)
Universitair Ziekenhuis Leuven (BE)
Ghent University Hospital (BE)
Corresponding author: Raj, Dominic S.
ORCID: Ramezani, Ali
Massy, Ziad A.
Meijers, Björn
Evenepoel, Pieter
Vanholder, Raymond
Raj, Dominic S.
Venue: American Journal of Kidney Diseases
Publisher: Elsevier BV
Published: 2016-03
Volume: 67
Issue: 3
Pages: 483-498
ISSN: 0272-6386 (ISSN-L)
DOI: 10.1053/j.ajkd.2015.09.027
PMC: PMC5408507
OpenAlex: W2180350916
Cited by: 394
References: 165
Citations by year: 2026: 27 · 2025: 39 · 2024: 46 · 2023: 37 · 2022: 45 · 2021: 41 · 2020: 45 · 2019: 45 · 2018: 30 · 2017: 29 · 2016: 8
FWCI: 2.20
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: American Journal of Kidney Diseases (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Lirias (KU Leuven) (submittedVersion)
Funders: National Institutes of Health (1R01DK073665-01A1, 1U01DK099924-01, 1U01DK099914-01)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords: gut microbiota, uremia, chronic kidney disease, uremic toxins, dysbiosis, intestinal barrier dysfunction, short-chain fatty acids, protein fermentation, microbial translocation, cardiovascular disease, insulin resistance, protein-energy wasting, microbiota-based therapy
MeSH terms: Gastrointestinal Microbiome, Humans, Uremia, Disease Progression, Renal Insufficiency, Chronic, Early Medical Intervention, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks